| Schedule of Stock by Class |
Preferred stock outstanding as of March 31, 2026 consisted of the following: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Sales | | | | Preferred Stock Series | | Shares Sold | | Par Value | | Price / Share | | Total Proceeds | Series B (1) | | 412,684 | | $0.00001 | | $14.35 | | $ 5,920,000 | | Series B | | 219,383 | | $0.00001 | | $14.35 | | 3,147,136 | | | Series B | | 121,991 | | $0.00001 | | $14.35 | | 1,750,000 | | | Series B | | 640,143 | | $0.00001 | | $14.35 | | 9,182,844 | | | Total Series B | | 1,394,201 | | | | | | 19,999,980 | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Sales | | | | Preferred Stock Series | | Shares Sold | | Par Value | | Price / Share | | Total Proceeds | Series A-1 (2) | | 752,726 | | $0.00001 | | $1.65 | | 1,242,998 | | | Series A-2 | | 1,826,442 | | $0.00001 | | $3.30 | | 6,029,987 | | | Total Series A | | 2,579,168 | | | | | | 7,272,985 | | | | | | | | | | | | Total Series A and B | | 3,973,369 | | | | | | $ | 27,272,965 | |
_________________ (1)Total proceeds from this includes warrants (2)Series A-1 were converted SAFEs originally issued in 2023 and 2024
|
Preferred stock sold during the year ended December 31, 2025 consisted of the following: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Preferred Stock Series | | Three Months Ended | | Shares Sold | | Par Value | | Sales Price / Share | | Total Proceeds | Series B(1) | | March 31, 2025 | | 412,684 | | $ | 0.00001 | | | $ | 14.35 | | | $ | 5,920,000 | | | Series B | | June 30, 2025 | | 219,383 | | $ | 0.00001 | | | $ | 14.35 | | | 3,147,136 | | | Series B | | September 30, 2025 | | 121,991 | | $ | 0.00001 | | | $ | 14.35 | | | 1,750,000 | | | Series B | | December 31, 2025 | | 640,143 | | $ | 0.00001 | | | $ | 14.35 | | | 9,182,844 | | | | | | 1,394,201 | | | | | | $ | 19,999,980 | |
___________________ (1)Total proceeds from this includes warrants Preferred stock sold and SAFEs converted to preferred stock during December 31, 2024 consisted of the following: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Preferred Stock Series | | Date Converted/Sold | | Shares Converted/Sold | | Par Value | | Sales Price / Share | | Total Proceeds | Series A-1(1) | | April 5 2024 | | 752,726 | | | $ | 0.00001 | | | $ | 1.65 | | | $ | 1,241,998 | | | Series A-2 | | April 5 2024 | | 1,826,442 | | | $ | 0.00001 | | | $ | 3.30 | | | 6,029,987 | | Total | | | | 2,579,168 | | | | | | | $ | 7,271,985 | |
__________________ (1)Series A-1 were converted SAFEs originally issued in 2023 and 2024.
|